论文信息 - The pharmacokinetics of 12-week continuous contraceptive patch use. - 字舞流文

The pharmacokinetics of 12-week continuous contraceptive patch use.

D. Rybin | A. Lavelanet | K. White

[1] W. Jusko. Perspectives on variability in pharmacokinetics of an oral contraceptive product. , 2017, Contraception.

[2] P. Harris,et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[3] M. Gold,et al. Extended cycling of combined hormonal contraceptives in adolescents: physician views and prescribing practices. , 2007, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[4] M. W. van den Heuvel,et al. Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive. , 2005, Contraception.

[5] J. Natarajan,et al. Pharmacokinetic overview of Ortho Evra/Evra. , 2002, Fertility and sterility.

[6] J. Natarajan,et al. Multiple-dose pharmacokinetics of a contraceptive patch in healthy women participants. , 2001, Contraception.